Cargando…
Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report
Adenoid cystic carcinoma (ACC) is a rare salivary glands tumor and often displays aggressive behavior with frequent relapse and metastasis. The terminal ACC lacks standard treatment guidelines and is always accompanied by poor prognosis. Here, we report a case of rare perianal ACC who received resec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670344/ https://www.ncbi.nlm.nih.gov/pubmed/34321419 http://dx.doi.org/10.1097/CAD.0000000000001171 |
_version_ | 1784614960678043648 |
---|---|
author | Zheng, Shengnan Li, Huiying Lin, Yongjuan Xie, Yu Yin, Zhenyu Ge, Weihong Yu, Tingting |
author_facet | Zheng, Shengnan Li, Huiying Lin, Yongjuan Xie, Yu Yin, Zhenyu Ge, Weihong Yu, Tingting |
author_sort | Zheng, Shengnan |
collection | PubMed |
description | Adenoid cystic carcinoma (ACC) is a rare salivary glands tumor and often displays aggressive behavior with frequent relapse and metastasis. The terminal ACC lacks standard treatment guidelines and is always accompanied by poor prognosis. Here, we report a case of rare perianal ACC who received resection and palliative adjuvant radiation. Five years later, PET-computed tomography (CT) showed perianal recurrence and multiple pulmonary metastases. Combined chemotherapy with doxorubicin, carboplatin and cyclophosphamide was applied for two cycles but ineffective. Further next-generation sequencing analysis of perianal tissue demonstrated the v-myb avian myelobastosis viral oncogene homolog and nuclear factor I/B fusion gene and two novel BCL-6 corepressor (BCOR) mutations (p.F1106Tfs*5 and p.L1524Hfs*8). The therapy was switched to eribulin and anlotinib and has been performed for eight cycles. At recent follow-ups, MRI and CT examinations revealed the diminishing perianal and pulmonary lesions. This study presented the first case of perianal ACC with multiple pulmonary metastases and particular BCOR mutations, who presented a durable response to eribulin and anlotinib, providing a potential therapeutic option for advanced refractory ACC. |
format | Online Article Text |
id | pubmed-8670344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86703442021-12-15 Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report Zheng, Shengnan Li, Huiying Lin, Yongjuan Xie, Yu Yin, Zhenyu Ge, Weihong Yu, Tingting Anticancer Drugs Clinical Reports Adenoid cystic carcinoma (ACC) is a rare salivary glands tumor and often displays aggressive behavior with frequent relapse and metastasis. The terminal ACC lacks standard treatment guidelines and is always accompanied by poor prognosis. Here, we report a case of rare perianal ACC who received resection and palliative adjuvant radiation. Five years later, PET-computed tomography (CT) showed perianal recurrence and multiple pulmonary metastases. Combined chemotherapy with doxorubicin, carboplatin and cyclophosphamide was applied for two cycles but ineffective. Further next-generation sequencing analysis of perianal tissue demonstrated the v-myb avian myelobastosis viral oncogene homolog and nuclear factor I/B fusion gene and two novel BCL-6 corepressor (BCOR) mutations (p.F1106Tfs*5 and p.L1524Hfs*8). The therapy was switched to eribulin and anlotinib and has been performed for eight cycles. At recent follow-ups, MRI and CT examinations revealed the diminishing perianal and pulmonary lesions. This study presented the first case of perianal ACC with multiple pulmonary metastases and particular BCOR mutations, who presented a durable response to eribulin and anlotinib, providing a potential therapeutic option for advanced refractory ACC. Lippincott Williams & Wilkins 2021-07-30 2022-01 /pmc/articles/PMC8670344/ /pubmed/34321419 http://dx.doi.org/10.1097/CAD.0000000000001171 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Clinical Reports Zheng, Shengnan Li, Huiying Lin, Yongjuan Xie, Yu Yin, Zhenyu Ge, Weihong Yu, Tingting Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title | Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title_full | Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title_fullStr | Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title_full_unstemmed | Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title_short | Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
title_sort | treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report |
topic | Clinical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670344/ https://www.ncbi.nlm.nih.gov/pubmed/34321419 http://dx.doi.org/10.1097/CAD.0000000000001171 |
work_keys_str_mv | AT zhengshengnan treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT lihuiying treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT linyongjuan treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT xieyu treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT yinzhenyu treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT geweihong treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport AT yutingting treatmentresponsetoeribulinandanlotinibinlungmetastasesfromrareperianaladenoidcysticcarcinomaacasereport |